Lobbying disclosures · Lobbying report
DVA: third_quarter 2026 lobbying report
Healthcare reimbursement policies; and issues relating to ESRD policies. Issues related to the budget and appropriations process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S.1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act
Follow DVA- Became public
- Oct 20, 2026, 10:45 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 12, 2026, 12:57 AM EST
Why this is connected
Exact legal-name match: DAVITA INC. (https://www.sec.gov/Archives/edgar/data/927066/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/1ec5c65e-9ae5-4c1c-8d15-1456b2539c6f/","filing_uuid":"1ec5c65e-9ae5-4c1c-8d15-1456b2539c6f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/1ec5c65e-9ae5-4c1c-8d15-1456b2539c6f/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul A. Brathwaite","dt_posted":"2026-10-20T22:45:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1220 L Street, NW","registrant_address_2":"Suite 100-401","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104703,"url":"https://lda.gov/api/v1/registrants/401104703/","house_registrant_id":null,"name":"FEDERAL STREET STRATEGIES, LLC","description":"Government relations and public policy consulting firm","address_1":"1220 L Street, NW","address_2":"Suite 100-401","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL BRATHWAITE","contact_telephone":"+1 202-274-1099","dt_updated":"2026-07-30T23:17:42.705814-04:00"},"client":{"id":202406,"url":"https://lda.gov/api/v1/clients/202406/","client_id":24,"name":"DAVITA, INC.","general_description":"Healthcare Service provider","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-12-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Healthcare reimbursement policies; and issues relating to ESRD policies. Issues related to the budget and appropriations process.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67337,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"BRATHWAITE","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.","new":false},{"lobbyist":{"id":142566,"prefix":null,"prefix_display":null,"first_name":"VEN","nickname":null,"middle_name":null,"last_name":"NERALLA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff, U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep. Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio; Senior Advisor, USDA; OPP; and MCC.","new":true},{"lobbyist":{"id":147906,"prefix":null,"prefix_display":null,"first_name":"KAADE","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum","new":true},{"lobbyist":{"id":147905,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"LEAVANDOSKY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S.1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67337,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"BRATHWAITE","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.","new":false},{"lobbyist":{"id":142566,"prefix":null,"prefix_display":null,"first_name":"VEN","nickname":null,"middle_name":null,"last_name":"NERALLA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff, U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep. Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio; Senior Advisor, USDA; OPP; and MCC.","new":true},{"lobbyist":{"id":147906,"prefix":null,"prefix_display":null,"first_name":"KAADE","nickname":null,"middle_name":null,"last_name":"WALLACE","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum","new":true},{"lobbyist":{"id":147905,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"LEAVANDOSKY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in DVA
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 7, 2025$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 7, 2025 · Joint
- Jan 17, 2024$1K–$15K
Sen. Jerry Moran (R-KS)
$1K–$15K · Traded Dec 14, 2023 · disclosed Jan 17, 2024
- Jan 17, 2024$1K–$15K
Sen. Jerry Moran (R-KS)
$1K–$15K · Traded Dec 14, 2023 · disclosed Jan 17, 2024 · Spouse
- Jan 12, 2024$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Dec 12, 2023 · disclosed Jan 12, 2024 · Joint
- Jul 14, 2023$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Jun 12, 2023 · disclosed Jul 14, 2023 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.